下一个

自动播放

Acute Lymphoblastic Leukemia: Optimizing MRD Testing

0 意见 • 06/15/23
分享
嵌入
administrator
administrator
订户
0

Mark R. Litzow, MD; Anthony S. Stein, MD; Aaron C. Logan, MD, PhD; and Bijal D. Shah, MD, reflect on the optimal time to test for minimal residual disease and how to best interpret the results regarding the prognosis of a patient with acute lymphoblastic leukemia.

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放